 |
Learn from the Experts! |
The Legionella bacteria is believed to be the indoor building contaminant most likely to result in mortality. Often perceived as rare, Legionnaires' disease is more common than many health and safety professionals recognize. Up to 25,000 cases of Legionnaires' disease occur every year in the United States*. The human and financial costs associated with an outbreak, or even an isolated case, greatly exceed $1 Million dollars. yet, the cost of prevention is mere pennies in comparison. This Bureau Veritas seminar will provide a general understanding of Legionella and other waterborne pathogens, where these pathogens amplify, how they disseminate into the indoor environment and how they present a serious risk to one’s health, and to the bottom lines of organizations. |
Participants will learn what standards and regulations exist regarding Legionella and what cost-effective options are available to assess the risk of Legionnaires’ Disease in their facilities. Know what’s in your water. Move Forward with Confidence knowing that with Bureau Veritas on your team, the answers are just a seminar away. *Data from the Centers for Disease Control |
| Who Should Attend? | Designed for building owners and managers, safety managers, plant managers, industrial hygienists, engineers, healthcare facility engineers, risk managers, loss control professionals, infections control professionals, construction project managers, insurance brokers, and human resource managers who are responsible for property management, indoor environmental quality in their buildings, and employee safety and productivity. |
 |
|
| CM Points | 1.0 CM Points |
|
|
| Dates/Times | Wednesday |
|
|
| Location | Bureau Veritas North America, Inc. |
|
|
Presenter
|
Steve Rupkey, CIH Steve Rupkey has over 20 years of experience in occupational Health and Safety and Environmental management. He specializes in Indoor Environmental Quality (IEQ) investigations, including inspection and sampling for fungal contamination in the indoor environment, and has performed many IEQ and ventilation surveys at government facilities, academic institutions, and manufacturing sites. Mr. Rupkey conducts IEQ, fungal and Legionella bacteria evaluations following the guidelines of the American Conference of Governmental Industrial Hygienists, the American Industrial Hygiene Association and the in-house guidelines of Bureau Veritas North America, Inc., Health, Safety and Environmental Services. |
|
|
Presenter
|
Gunner Lyslo Gunner Lyslo, president and CEO of EBSol, Inc., is a leader in the research and prevention of Legionnaires’ disease and its causative agent, Legionella. Mr. Lyslo has paid specific attention toward disinfection modalities and has worked extensively on the advantages and disadvantages regarding the use of various short term and long term disinfection options. Recently, his focus has been applied toward emerging waterborne pathogens such as Pseudomonas, Acineterbacter, Stenotrophomonas maltophilia and Aspergillus. Mr. Lyslo has presented nationally to numerous groups including local APIC and ASHE Chapters. EBSol, Inc. is a leading Legionella consulting firm whose recommendations are based on the criteria of evidenced-based medicine. They have worked extensively with health care providers and industry leaders throughout the US and have guided many health departments on this complicated issue. EBSol's team of experts includes: Infectious Diseases physicians, Microbiologists, Engineers and Project managers. |
